In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treatment options and recent FDA approval. Listen to the episode to learn about the current standard of care and future therapies with a brief discussion about small cell transformation.

Guest: Triparna Sen, MD
Associate Professor
Director, Lung Cancer PDX Program,
Icahn School of Medicine at Mount Sinai

Guest:

Jacob Sands, MD
Assistant Professor of Medicine, Harvard Medical School
Lowe Cancer Center for Thoracic Oncology
Dana Farber Cancer Institute

Ver todos los episodios